ARS Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-2,999
| Closed | -$336K | – | 187 |
|
2021
Q4 | $336K | Sell |
2,999
-271
| -8% | -$30.4K | 0.03% | 131 |
|
2021
Q3 | $411K | Sell |
3,270
-346
| -10% | -$43.5K | 0.04% | 113 |
|
2021
Q2 | $490K | Sell |
3,616
-644
| -15% | -$87.3K | 0.05% | 98 |
|
2021
Q1 | $578K | Sell |
4,260
-721
| -14% | -$97.8K | 0.07% | 89 |
|
2020
Q4 | $701K | Buy |
4,981
+1,805
| +57% | +$254K | 0.09% | 75 |
|
2020
Q3 | $354K | Buy |
+3,176
| New | +$354K | 0.06% | 83 |
|